CPRC
CLOV icon

Consolidated Portfolio Review Corp’s Clover Health Investments CLOV Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-104,442
Closed -$320K – 108
2025
Q3 		$320K Buy
104,442
+66,868
+178% +$191K 0.04% 358
2025
Q2 		$105K Buy
+37,574
New +$124K 0.01% 439

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Consolidated Portfolio Review Corp's CLOV Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Clover Health Investments (CLOV) in Q4 2025, closing a stake of 104,442 shares — an estimated $320K sold.

Consolidated Portfolio Review Corp first reported a position in CLOV in Q2 2025 and held it in 2 quarters. The position peaked at $320K in Q3 2025. 193 funds tracked by Wall St. Rank hold CLOV as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Clover Health Investments position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 104,442 Clover Health Investments shares in Q4 2025, an estimated $320K.
  • Consolidated Portfolio Review Corp first reported a position in Clover Health Investments in Q2 2025 and held it in 2 quarters.
  • Consolidated Portfolio Review Corp's Clover Health Investments position peaked at $320K in Q3 2025.
  • 193 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.